213. VYBOROChNOE FARMAKOEPIDEMIOLOGIChESKOE ISSLEDOVANIE REVMATOIDNOGO ARTRITA.

by A L Khokhlov, O V Ershova
Published 2000-08-01

Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19

by O. V. Zhukova, A. L. Khokhlov
Published 2021-04-01

Genetic testing for forecasting and course of the chronic heart failure against the background arterial hypertension

by A. L. Khokhlov, Yu. V. Rybachkova
Published 2018-02-01

Analysis of the quality of bioequivalence and pharmacokinetics studies in Russia Federation

by A. L. Khokhlov, E. G. Lileeva
Published 2018-05-01

SILVER NANOPARTICLES IN THE SOLUTION OF THE PROBLEM OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS

by A. V. Zaharov, A. L. Khokhlov, A. E. Ergeshov
Published 2017-05-01

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products

by A. L. Khokhlov, D. P. Romodanovsky, A. E. Miroshnikov
Published 2019-09-01

Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic

by D. P. Romodanovsky, A. L. Khokhlov, D. V. Goryachev
Published 2021-03-01

Planning and Evaluation of Bioequivalence Studies of Enalapril Products

by D. P. Romodanovsk, A. L. Khokhlov, A. E. Miroshnikov
Published 2018-12-01

COMPARATIVE ANALYSIS OF DRUG EFFICACY IN THE TREATMENT FOR COVID-19 SEVERE FORMS, BASED ON ATTRIBUTE-BASED STATISTIC METHODS AND ANALYSIS OF DRUG INTERACTIONS

by O. V. Zhukova, I. N. Kagramanyan, A. L. Khokhlov
Published 2021-03-01

Renal functional state in patients with myocardial infarction

by O N Kurochkina, A L Khokhlov, A N Bogomolov
Published 2013-04-01

PHARMACOEPIDEMIOLOGY OF PHYSICIANS’ INDICATIONS IN PATIENTS WITH POSTINFARCTIONCARDIOSCLEROSIS

by O. N. Kurochkinа, A. L. Khokhlov, N. M. Boyankova
Published 2015-03-01

INFLUENCE OF SEX DIFFERENCES ON PHARMACOKINETICS OF DRUGS WITHIN THE FRAMEWORK OF BIOEQUIVALENCE STUDIES OF GENERIC MEDICINAL PRODUCTS

by D. P. Romodanovsky, D. V. Goryachev, A. L. Khokhlov, A. E. Miroshnikov
Published 2018-09-01

FEATURES OF THE CLINICAL SIGNIFICANCE OF POLYMORPHIC VARIANTS OF ENOS AND AGTR2 GENES IN PATIENTS WITH CAD

by A. L. Khokhlov, N. O. Pozdnyakov, A. E. Miroshnikov, I. N. Tzareva, S. O. Pozdnyakov
Published 2016-06-01

METHODS OF STABILIZATION OF DRUG SUBSTANCES AND THEIR METABOLITES IN BIOLOGICAL FLUIDS DURING BIOANALYTICAL STUDY (REVIEW)

by I. I. Yaichkov, A. L. Khokhlov, Y. A. Dzhurko, L. N. Shitov, A. A. Trubnikov
Published 2019-01-01

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS

by A. V. Zаkhаrov, A. E. Ergeshov, A. L. Khokhlov, B. S. Kibrik
Published 2017-06-01

Risks associated with the ethical aspects of conducting clinical trials

by A. L. Khokhlov, E. A. Polozova, V. A. Komissarova, N. V. Chudova, L. G. Tsyzman
Published 2020-05-01

APPROACHES TO THE DEVELOPMENT OF BIOANALYTICAL METHODS FOR DETERMINATION OF UNSTABLE SUBSTANCES IN BIOLOGICAL FLUIDS

by A. L. Khokhlov, I. I. Yaichkov, Yu. A. Dzhurko, M. Ryska, V. Kubeš, L. N. Shitov
Published 2018-09-01

OBITUARY FOR YURI N. CHERNOV 5 Nov 1937 – 1 Jan 2021

by M. V. Vasin, I. E. Esaulenko, V. G. Kukes, V. I. Petrov, I. B. Ushakov, A. L. Khokhlov
Published 2021-06-01

PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROSCLEROSIS

by A. L. Khokhlov, A. N. Yavorsky, N. O. Pozdnyakov, J. V. Rybachkova, E. S. Emelianov, A. A. Khokhlov, A. E. Miroshnikov, S. O. Pozdnyakov
Published 2018-02-01

The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)

by A. O. Mariandyshev, A. L. Khokhlov, S. V. Smerdin, V. S. Shcherbakova, O. V. Igumnova, I. V. Ozerova, A. A. Bolgarina, N. A. Nikitina
Published 2020-03-01